CLIC-1901
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CLIC-1901, covering 2025-08-14 to 2025-08-14. Get the full timeline:
Most recent: Clinical Trial Update: CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies [Phase 1, Phase 2]